Genetic variation in osteopontin gene is associated with susceptibility to sarcoidosis in Slovenian population

Disease Markers

Volumn 27, Issue 6, 2009, Pages 295-302

  Maver, A ^a   Medica, I ^a   Salobir, B ^a   Tercelj, M ^a   Peterlin, B ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Association study; Haplotype; Osteopontin; Polymorphism; Sarcoidosis

Indexed keywords

OSTEOPONTIN;

ARTICLE; CHI SQUARE TEST; CHILD; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SARCOIDOSIS; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SLOVENIA;

EID: 77249086584     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0675     Document Type: Article

References (32)

1. G.W. Hunninghake, U. Costabel, M. Ando, R. Baughman, J.F. Cordier, R. Du Bois, A. Eklund, M. Kitaichi, J. Lynch, G. Rizzato, C. Rose, O. Selroos, G. Semenzato and O.P. Sharma, ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders, Sarcoidosis Vasc Diffuse Lung Dis 16 (1999), 149-173. (Pubitemid 29469097)
2. E.M. Gravallese, Osteopontin: a bridge between bone and the immune system, J Clin Invest 112 (2003), 147-149.
3. I. Carlson, K. Tognazzi, E.J. Manseau, H.F. Dvorak and L.F. Brown, Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology, Lab Invest 77 (1997), 103-108.
4. M. Jansson, V. Panoutsakopoulou, J. Baker, L. Klein and H. Cantor, Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice, J Immunol 168 (2002), 2096-2099.
5. A.W. O'Regan, G.L. Chupp, J.A. Lowry, M. Goetschkes, N. Mulligan and J.S. Berman, Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro, J Immunol 162 (1999), 1024-1031.
6. F. Giacopelli, R. Marciano, A. Pistorio, P. Catarsi, S. Canini, G. Karsenty and R. Ravazzolo, Polymorphisms in the osteopontin promoter affect its transcriptional activity, Physiol Genomics 20 (2004), 87-96.
7. A. Mas, A. Martinez, V. de las Heras, M. Bartolome, E.G. de la Concha, R. Arroyo and E. Urcelay, The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish population, Mult Scler 13 (2007), 250-252.
8. S. D'Alfonso, N. Barizzone, M. Giordano, A. Chiocchetti, C. Magnani, L. Castelli, M. Indelicato, F. Giacopelli, M. Marchini, R. Scorza, M.G. Danieli, M. Cappelli, S. Migliaresi, B. Bigliardo, M.G. Sabbadini, E. Baldissera, M. Galeazzi, G.D. Sebastiani, G. Minisola, R. Ravazzolo, U. Dianzani and P. Momigliano-Richiardi, Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus, Arthritis Rheum 52 (2005), 539-547.
9. D.J. Schaid, C.M. Rowland, D.E. Tines, R.M. Jacobson and G.A. Poland, Score tests for association between traits and haplotypes when linkage phase is ambiguous, AmJHumGenet 70 (2002), 425-434.
10. M. Stephens, N.J. Smith and P. Donnelly, A new statistical method for haplotype reconstruction from population data, Am J Hum Genet 68 (2001), 978-989.
11. J.C. Barrett, B. Fry, J. Maller and M.J. Daly, Haploview: analysis and visualization of LD and haplotype maps, Bioinformatics 21 (2005), 263-265.
12. Y. Benjamini and Y. Hochberg, False discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc B 57 (1995), 289-300.
13. K. Maeda, K. Takahashi, F. Takahashi, N. Tamura, M. Maeda, S. Kon, T. Uede and Y. Fukuchi, Distinct roles of osteopontin fragments in the development of the pulmonary involvement in sarcoidosis, Lung 179 (2001), 279-291.
14. M. Mazzali, T. Kipari, V. Ophascharoensuk, J.A. Wesson, R. Johnson and J. Hughes, Osteopontin-a molecule for all seasons, QJM 95 (2002), 3-13.
15. D.T. Denhardt and X. Guo, Osteopontin: a protein with diverse functions, FASEB J 7 (1993), 1475-1482.
16. S. Ashkar, G.F. Weber, V. Panoutsakopoulou, M.E. Sanchirico, M. Jansson, S. Zawaideh, S.R. Rittling, D.T. Denhardt, M.J. Glimcher and H. Cantor, Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity, Science 287 (2000), 860-864.
17. E.R. O'Brien, M.R. Garvin, D.K. Stewart, T. Hinohara, J.B. Simpson, S.M. Schwartz and C.M. Giachelli, Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques, Arterioscler Thromb 14 (1994), 1648-1656.
18. A.W. O'Regan, J.M. Hayden, S. Body, L. Liaw, N. Mulligan, M. Goetschkes and J.S. Berman, Abnormal pulmonary granuloma formation in osteopontin-deficient mice, Am J Respir Crit Care Med 164 (2001), 2243-2247.
19. E.E. Rollo, D.L. Laskin and D.T. Denhardt, Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages, J Leukoc Biol 60 (1996), 397-404.
20. G.J. Nau, G.L. Chupp, J.F. Emile, E. Jouanguy, J.S. Berman, J.L. Casanova and R.A. Young, Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection, Am J Pathol 157 (2000), 37-42.
21. G.J. Nau, L. Liaw, G.L. Chupp, J.S. Berman, B.L. Hogan and R.A. Young, Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin, Infect Immun 67 (1999), 4223-4230.
22. K.X. Wang and D.T. Denhardt, Osteopontin: role in immune regulation and stress responses, Cytokine Growth Factor Rev 19 (2008), 333-345.
23. J.S. Berman, D. Serlin, X. Li, G. Whitley, J. Hayes, D.C. Rishikof, D.A. Ricupero, L. Liaw, M. Goetschkes and A.W. O'Regan, Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice, Am J Physiol Lung Cell Mol Physiol 286 (2004), L1311-L1318.
24. L. de las Fuentes, C.C. Gu, S.J. Mathews, J.L. Reagan, N.P. Ruthmann, A.D. Waggoner, C.F. Lai, D.A. Towler and V.G. Davila-Roman, Osteopontin promoter polymorphism is associated with increased carotid intima-media thickness, J Am Soc Echocardiogr 21 (2008), 954-960.
25. S. Han, J.M. Guthridge, I.T. Harley, A.L. Sestak, X. Kim- Howard, K.M. Kaufman, B. Namjou, H. Deshmukh, G. Bruner, L.R. Espinoza, G.S. Gilkeson, J.B. Harley, J.A. James and S.K. Nath, Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction, PLoS ONE 3 (2008), e0001757.
26. B. Gao, T. Yasui, Y. Itoh, Z. Li, A. Okada, K. Tozawa, Y. Hayashi and K. Kohri, Association of osteopontin gene haplotypes with nephrolithiasis, Kidney Int 72 (2007), 592-598.
27. D. Hendig, M. Arndt, C. Szliska, K. Kleesiek and C. Gotting, SPP1 promoter polymorphisms: identification of the first modifier gene for pseudoxanthoma elasticum, Clin Chem 53 (2007), 829-836.
28. S. Caillier, L.F. Barcellos, S.E. Baranzini, A. Swerdlin, R.R. Lincoln, L. Steinman, E. Martin, J.L. Haines, M. Pericak- Vance, S.L. Hauser and J.R. Oksenberg, Osteopontin polymorphisms and disease course in multiple sclerosis, Genes Immun 4 (2003), 312-315.
29. M. Akahoshi, M. Ishihara, N. Remus, K. Uno, K. Miyake, T. Hirota, K. Nakashima, A. Matsuda, M. Kanda, T. Enomoto, S. Ohno, H. Nakashima, J.L. Casanova, J.M. Hopkin, M. Tamari, X.Q. Mao and T. Shirakawa, Association between IFNA genotype and the risk of sarcoidosis, Hum Genet 114 (2004), 503-509.
30. J. Hull, S. Campino, K. Rowlands, M.S. Chan, R.R. Copley, M.S. Taylor, K. Rockett, G. Elvidge, B. Keating, J. Knight and D. Kwiatkowski, Identification of common genetic variation that modulates alternative splicing, PLoS Genet 3 (2007), e99.
31. M. Li, M. Boehnke and G.R. Abecasis, Joint modeling of linkage and association: identifying SNPs responsible for a linkage signal, Am J Hum Genet 76 (2005), 934-949.
32. R.W. Morris and N.L. Kaplan, On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles, Genet Epidemiol 23 (2002), 221-233.